Number of Clinical Trials 2016
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Newer data is available: Number of Clinical Trials by country 2024 β
Where does your country rank? Pick it to see its position.
Related Health statistics
More βInteractive Map
Complete Data Rankings
- #1
United States
- #2
France
- #3
United Kingdom
- #4
Canada
- #5
Germany
- #6
China
- #7
South Korea
- #8
Spain
- #9
Denmark
- #10
Brazil
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #133
Suriname
- #132
Sudan
- #131
Papua New Guinea
- #130
Montenegro
- #129
Mongolia
- #128
Martinique
- #127
Malta
- #126
Madagascar
- #125
Liberia
- #124
Guinea
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
France
In 2016, France ranked #2 globally with a total of 943 clinical trials. This figure is significantly higher than many European neighbors, reflecting France's robust pharmaceutical and biotechnology sectors. The country's strong emphasis on research and development, supported by government initiatives and a well-established healthcare system, drives its prominence in clinical research.
China
In 2016, China ranked #6 globally with a total of 458 clinical trials. This number is significant compared to the global average, reflecting China's increasing prominence in the clinical research landscape. The country's rapid economic growth, large population, and government support for innovative healthcare initiatives have catalyzed this expansion in clinical trials.
Congo, Democratic Republic of the
Congo, Democratic Republic of the ranked #80 globally with a total of 4 clinical trials in 2016. This figure is notably low compared to many neighboring countries, highlighting challenges in clinical research infrastructure. Factors such as limited healthcare investment, ongoing political instability, and logistical difficulties in conducting research in remote areas contribute to this low number, impacting the country's ability to attract international clinical studies.
CΓ΄te d'Ivoire
CΓ΄te d'Ivoire ranked #124 globally with a total of 1 clinical trial in 2016. This figure is significantly lower than the global average, indicating limited engagement in clinical research compared to more developed nations. Contributing factors include a lack of funding for medical research and infrastructural challenges that hinder the establishment of clinical trial networks.
Morocco
In 2016, Morocco ranked #104 globally with a total of 2 clinical trials. This figure is notably lower than many neighboring countries, reflecting a regional trend where Morocco lags behind in clinical research initiatives. Contributing factors include limited investment in healthcare infrastructure and a relatively small population engaged in clinical research, which hinders the country's ability to attract and conduct more trials.
Equatorial Guinea
In 2016, Equatorial Guinea had a global rank of #121 with a total of 1 clinical trial. This figure is notably low, especially when compared to the highest-ranked country, the United States, which hosts thousands of clinical trials annually. The limited number of clinical trials in Equatorial Guinea can be attributed to its small population, economic challenges, and a lack of robust healthcare infrastructure and research funding.
Myanmar
In 2016, Myanmar ranked #96 globally with a total of 2 clinical trials. This number is significantly lower compared to regional neighbors, reflecting challenges in healthcare infrastructure and research funding. The limited number of clinical trials in Myanmar can be attributed to ongoing political and economic instability, which hampers investment in medical research and development.
Japan
In 2016, Japan ranked #12 globally with a total of 237 clinical trials. This figure is significant, especially when compared to its regional peers in Asia, where many countries have fewer trials. Japan's advanced healthcare system, substantial investment in research and development, and a strong regulatory framework contribute to its robust clinical trial landscape.
India
In 2016, India ranked #20 globally with a total of 115 clinical trials. This figure is notable compared to countries like Brazil, which had fewer trials, highlighting India's growing role in the global clinical research landscape. Contributing factors include a large and diverse patient population, a robust pharmaceutical industry, and government policies aimed at promoting medical research and development.
Iceland
In 2016, Iceland ranked #90 globally with a total of 3 clinical trials. This figure is notably lower than many of its Nordic neighbors, reflecting a limited research infrastructure in the country. The small population and geographic isolation of Iceland contribute to challenges in attracting large-scale clinical research initiatives, impacting the overall number of trials conducted.
Analysis & Context
In 2016, the United States led the world in the Number of Clinical Trials with a staggering 5,873, while the global range spanned from a minimum of 1 to the maximum observed in the US. The global average for clinical trials across the 133 countries with available data was 103.65, highlighting a significant concentration of research activity in a few key nations.
Concentration of Clinical Trials in Developed Nations
The distribution of clinical trials in 2016 reveals a clear concentration in developed nations, with the United States, France, and the United Kingdom at the forefront. The US's leading position with 5,873 trials is not only a reflection of its advanced healthcare system but also its substantial investment in medical research and development. Similarly, France conducted 943 trials, and the United Kingdom had 611. These countries benefit from robust infrastructure, extensive research funding, and a collaborative environment between universities, hospitals, and the pharmaceutical industry.
In contrast, the bottom 10 countries, including Cyprus, Montenegro, and Equatorial Guinea, each reported just 1 clinical trial. This vast disparity underscores the challenges faced by developing nations in accessing resources necessary for conducting medical research.
Economic and Policy Drivers
Economic capability and supportive policies are critical drivers behind the number of clinical trials conducted in a country. The high numbers in countries such as Germany with 501 trials and Canada with 588 can be attributed to their stable economies and government incentives for research and development. Conversely, countries with fewer trials often lack the financial resources and policy frameworks to support large-scale clinical research.
- Germany experienced a decrease of 76 trials from the previous year, indicating potential shifts in research funding or regulatory environments.
- Egypt, although not among the top 10, saw a significant increase of 73 trials, a 74.5% rise, possibly due to recent policy changes fostering research investments.
Year-over-Year Trends and Influences
The year-over-year changes provide insight into dynamic shifts within the global landscape of clinical trials. The United States saw the most significant numerical increase with an addition of 526 trials, reflecting ongoing innovation and capacity expansion in its healthcare sector. France and the United Kingdom also recorded substantial increases, with 135 and 85 additional trials, respectively, aligning with broader European Union initiatives to bolster medical research.
Meanwhile, Israel experienced a notable decline of 42 trials, a -27.8% change, potentially due to shifts in regional research priorities or funding reallocations. Similarly, Austria and Norway saw decreases, with -25 and -21 trials, respectively, reflecting possible changes in national research strategies or economic constraints.
Implications for Global Health Research
The concentration of clinical trials in a few countries has profound implications for global health research, particularly in terms of access to new treatments and medical advancements. The unequal distribution suggests that many regions may not benefit equally from breakthroughs in medical science, potentially widening the gap in healthcare quality and outcomes between developed and developing nations.
Efforts to increase the number of clinical trials in underrepresented regions could enhance global health equity. This might involve international collaborations, increased funding, and policy reforms aimed at creating conducive environments for medical research. By addressing these disparities, the global community can ensure that the benefits of medical innovation are more evenly distributed across all countries.
Frequently Asked Questions About Number of Clinical Trials in 2016
Which country had the highest number of clinical trials in 2016?
The United States had the highest number of clinical trials in 2016, with a total of 5,873.
Which country had the lowest number of clinical trials in 2016?
Cyprus had the lowest number of clinical trials in 2016, with only 1 trial conducted.
What was the average number of clinical trials per country in 2016?
The average number of clinical trials per country in 2016 was 104.
What was the median number of clinical trials per country in 2016?
The median number of clinical trials per country in 2016 was 7.
Which countries were in the top 3 for the number of clinical trials in 2016?
The top 3 countries for the number of clinical trials in 2016 were the United States with 5,873, France with 943, and the United Kingdom with 611.
How many countries had only 1 clinical trial in 2016?
There were 10 countries that had only 1 clinical trial in 2016.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2016. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2016
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
βΊEmbed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.